Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-24 @ 7:47 PM
NCT ID:
NCT01368003
Eligibility Criteria:
Inclusion Criteria:
* Adenocarcinoma of the prostate
* Progressive castration resistant disease
* Metastatic disease
* Normal organ and marrow function
Exclusion Criteria:
* History of current coronary artery disease, myocardial infarction, angina pectoris, angioplasty or coronary bypass
* Current treatment with the following antiarrhythmic drugs: flecainide, moricizine or propafenone
* New York Heart Association class II/III/IV congestive heart failure
* Current or prior radiation therapy to the left hemithorax
* Treatment with chronic immunosuppressants
* Uncontrolled intercurrent illness
* Poor venous access for study drug administration
* Venous thromboembolism in the past 6 months
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT01368003
Study Brief:
Protocol Section:
NCT01368003